Cite

HARVARD Citation

    Yokoyama, M. et al. (2013). Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. ISRN oncology. p. . [Online]. 
  
Back to record